Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020

The number of measles cases declined in European Union/European Economic Area countries and the United Kingdom in 2020. Reported cases to The European Centre for Disease Prevention and Control decreased from 710 to 54 between January and May. Epidemic intelligence screening observed a similar trend. Under-diagnoses and under-reporting during the coronavirus disease (COVID-19) pandemic should be ruled out before concluding reduced measles circulation is because of social distancing and any community control measures taken to control COVID-19.
Source: Eurosurveillance - Category: Infectious Diseases Authors: Source Type: research

Related Links:

Abstract The number of measles cases declined in European Union/European Economic Area countries and the United Kingdom in 2020. Reported cases to The European Centre for Disease Prevention and Control decreased from 710 to 54 between January and May. Epidemic intelligence screening observed a similar trend. Under-diagnoses and under-reporting during the coronavirus disease (COVID-19) pandemic should be ruled out before concluding reduced measles circulation is because of social distancing and any community control measures taken to control COVID-19. PMID: 32762795 [PubMed - in process]
Source: Euro Surveill - Category: Infectious Diseases Authors: Tags: Euro Surveill Source Type: research
By MICHEL ACCAD, MD With cases of COVID-19 either disappeared or rapidly diminishing from places like Wuhan, Italy, New York, and Sweden, many voices are speculating that herd immunity may have been reached in those areas and that it may be at hand in the remaining parts of the world that are still struggling with the pandemic.  Lockdowns should end—or may not have been needed to begin with, they conclude. Adding plausibility to their speculation is the discovery of biological evidence suggesting that prior exposure to other coronaviruses may confer some degree of immunity against SARS-CoV...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy immunity MICHEL ACCAD Pandemic Source Type: blogs
  The effect of coronavirus on the economy and our daily lives has been huge. COVID-19 has rightly dominated government and organization policies, social life, and media headlines so far this year – but are other diseases getting the right attention? Neglected diseases The World Health Organization maintains a department dedicated to the research and treatment of Neglected Tropical Diseases. These conditions are considered “neglected” by mainstream Medicine by virtue of a relative lack of impact and presence in Western countries. In January 2020, GIDEON listed 360 generic infectious diseases in huma...
Source: GIDEON blog - Category: Databases & Libraries Authors: Tags: News Source Type: blogs
At long last, we have made a truly game-changing scientific breakthrough in preventing the spread of COVID-19. The impact of this breakthrough seems almost too good to be true. We have found a disease control tool that, when used properly, can dramatically reduce the person-to-person transmission of SARS-CoV-2, the virus that causes COVID-19. Studies have shown that this tool could reduce transmission by somewhere between 50% and 85%. The tool is cheap and remarkably low-tech. You can even make one at home. It has no significant side effects. And with each passing day, the scientific research showing the tool’s effec...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Conclusion The story of COVID-19 contact tracing is still in progress, and it’s not clear whether the ending will be success or failure. We hope that this essay has added depth to the opening words “Contact tracing for COVID-19 will be the most complex health investigation ever”. Vince Kuraitis, JD/MBA (@VinceKuraitis) is an independent healthcare strategy consultant with over 30 years’ experience across 150+ healthcare organizations. He blogs at e-CareManagement.com. Eric D. Perakslis, PhD (@eperakslis) is a Rubenstein Fellow at Duke University. Deven McGraw , JD, MPH, LLM (@h...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy The Health Data Goldilocks Dilemma: Sharing? Privacy? Both? Deven McGraw Eric Perakslis Vince Kuraitis Source Type: blogs
Devyn Holliday, Research Officer, Economic, Youth &Sustainable Development Directorate   This blog is part of the seminar series on ‘The Economics of COVID-19’.By Devyn HollidayJun 10 2020 (IPS-Partners) When countries shuttered their shops, closed their markets, and cordoned off places of gathering to help ward off the coronavirus, they did so out of immediate concern for the health and wellbeing of their citizens. However, as these measures endure the virus is no longer the sole threat to the health and wellbeing of citizens. People across the globe are facing mounting threats to their wellbeing c...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Economy & Trade Health Labour Source Type: news
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
This article originally appeared on his blog here. The post The Problem With “Herd Immunity” as a COVID-19 Strategy appeared first on The Health Care Blog.
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy Dave deBronkart e-Patient Dave e-Patient Dave DeBronkart Pandemic Source Type: blogs
This article originally appeared on The Bulwark here. The post The False Choice Between Science And Economics appeared first on The Health Care Blog.
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy David Shaywitz Source Type: blogs
More News: Coronavirus | COVID-19 | Epidemics | Epidemiology | Infectious Diseases | Measles | Pandemics | UK Health